We are live on ! Find out more
REVBW icon

Revelation Biosciences Warrant

12 hedge funds and large institutions have $13.8K invested in Revelation Biosciences Warrant in 2025 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more first-time investments, than exits

New positions opened: 5 | Existing positions closed: 2

108.54% more ownership

Funds ownership: 11.8%120.33% (+109%)

33% more funds holding

Funds holding: 912 (+3)

31% more capital invested

Capital invested by funds: $10.5K → $13.8K (+$3.27K)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

Holders
12
Holders Change
+3
Holders Change %
+33.33%
% of All Funds
0.16%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
1
Reduced
1
Closed
2
Calls
Puts
Net Calls
Net Calls Change

REVBW Hedge Fund Activity: Q2 2025 in Review

12 of the 7,595 institutional investors tracked by Wall St. Rank reported a position in Revelation Biosciences Warrant (REVBW) for Q2 2025, worth a combined $13.8K — up 31% from $10.5K a quarter earlier.

Buyers outnumbered sellers: 5 funds opened new REVBW positions and 2 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Clear Street, opening a new position worth an estimated $3K. The largest seller was Yakira Capital Management, exiting entirely with an estimated $2.68K sold.

  • 12 institutional investors held Revelation Biosciences Warrant (REVBW) as of Q2 2025, up from 9 in Q1 2025.
  • Funds reported $13.8K of Revelation Biosciences Warrant stock for Q2 2025, up 31% quarter-over-quarter.
  • 5 funds opened new Revelation Biosciences Warrant positions in Q2 2025 and 2 closed out, a net change of +3 holders.
  • The largest Revelation Biosciences Warrant buyer in Q2 2025 was Clear Street, an estimated $3K added.
  • The largest Revelation Biosciences Warrant seller in Q2 2025 was Yakira Capital Management, an estimated $2.68K sold.

Based on aggregated 13F filings for Q2 2025.